Bill Ackman made nearly nearly $170 million in one day in a Valeant two-day rally. His comment on Valeant Pharmaceutical showed his capability as a remarkable hedge fund manager.
Tags: Bill ackman
Chipotle Addresses False Ownership Claims Amid Bill Ackman Donation Controversy
Chipotle clarifies it has no ties to Bill Ackman after his controversial ICE donation sparks false boycott claims.
Bill Ackman Unveils Plan for Fannie Mae and Freddie Mac, Could Return $300 Billion to Taxpayers
Bill Ackman unveils a plan to return $300 billion to taxpayers by reshaping Fannie Mae and Freddie Mac.
Bill Ackman's Bet on Beleaguered Hertz is Up 90% as Stock Jumps 35% After First Profits in Two Years
Bill Ackman's Pershing Square has bought over 15.2 million Hertz shares since Q4 2024, with profits exceeding 90% after the company reports its first profits in two years.
Melinda Gates Slams Generosity of Elon Musk, Peter Thiel, Denies Calling Them Philanthropists
Melinda French Gates, the ex-wife of Microsoft founder Bill Gates, said that the new generation of billionaires like Elon Musk, Peter Thiel, Jack Dorsey, and Bill Ackman are more vocal than financial in their efforts to make social changes.
Latest News
In the continuing saga on Valeant, CFO Howard Schiller has been asked to resign. The company will also find the replacement of CEO Michael Pearson, and putting Bill Ackman in its board.
Following Valeant Pharmaceuticals' meltdown, S&P rating service puts Pershing Square Holdings Ltd on review. However, S&P acknowledged swift decision by the firm to strengthen its liquidity after a massive loss.
A huge slump in Valeant Pharmaceutical stocks on Tuesday made Pershing Capital to lose more than $1 billion in one day. Meanwhile Bill Ackman planned to take more active role in the drugmaker.
The Canadian drugmaker on Wednesday announced to add three new directors to its board. Representative from Pershing Square Capital Management was added as one of the directors.
Pershing Square Holdings, a fund managed by activist investor Bill Ackman, raised $3.07 billion ahead of a stock market listing in Amsterdam, the company said on Wednesday.
T. Rowe Price, the second largest shareholder in Allergan Inc (AGN.N), said on Friday that it wants the company to hold off on making major moves before a Dec. 18 special shareholder meeting, and criticized the board on its corporate governance.
Pershing Square Holdings, a fund managed by activist investor Bill Ackman, hopes to raise $2 billion from a listing on the Euronext Amsterdam stock exchange, the company said in a statement on Monday.
Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.
With activist investors amassing wealth because of their campaigns, investment banks are now providing clients investment advice that would enable companies to anticipate and foil the efforts of activist investors, Bloomberg reported.
